Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure-Reference-Cited by-同舟云学术

Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure

Published:2018-06-01 Issue:6 Volume:3 Page:498
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Chandra Alvin¹,Lewis Eldrin F.¹,Claggett Brian L.¹,Desai Akshay S.¹,Packer Milton²,Zile Michael R.³,Swedberg Karl⁴⁵,Rouleau Jean L.⁵⁶,Shi Victor C.⁷,Lefkowitz Martin P.⁷,Katova Tzvetana⁸,McMurray John J. V.⁹,Solomon Scott D.¹

Affiliation:

1. Brigham and Women’s Hospital, Boston, Massachusetts

2. Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas

3. Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston

4. Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden

5. National Heart and Lung Institute, Imperial College, London, England

6. Institut Cardiologie de Montreal, Université de Montreal, Montreal, Quebec, Canada

7. Novartis, East Hanover, New Jersey

8. National Hospital of Cardiology, Sofia, Bulgaria

9. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Quality of life and symptoms of depression in advanced heart failure patients and their partners.;Jaarsma;Curr Opin Support Palliat Care,2010

3. Angiotensin-neprilysin inhibition versus enalapril in heart failure.;McMurray;N Engl J Med,2014

4. Health-related quality of life outcomes in PARADIGM-HF.;Lewis;Circ Heart Fail,2017

5. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.;Veazie;J Am Coll Cardiol,2012

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic heart failure with reduced EF: A decade of major pharmacological innovations;La Presse Médicale;2024-03

2. Impact of Treatment With Sacubitril/Valsartan on Erectile Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction;The American Journal of Cardiology;2024-02

3. Effect of angiotensin receptor neprilysin inhibitor on physical activity in patients with heart failure with reduced ejection fraction, monitored by implantable electronic device home monitoring;Journal of Cardiovascular Medicine;2024-01-23

4. Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Cureus;2023-11-11

5. Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction;JACC: Heart Failure;2023-10